In conclusion, this study provides a new insight into HCC cell migration and metastasis through the regulation of the Erk1/2-Elk-1 pathway and helps identify a new therapeutic target for HCC metastasis. This evidence concerns the gene MAPK3 and hepatocellular carcinoma.